RETA

Reata Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Reata Pharmaceuticals Inc RETA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.92 3.42% 27.80 20:00:00
Open Price Low Price High Price Close Price Prev Close
27.83 25.86 28.25 27.80 26.88
more quote information »

Recent News

Date Time Source Heading
5/26/202210:07IHNWFeaturedEmerging Markets Report: A Case for Uranium
5/26/20229:07IHNWFeaturedGrove Inc. Upexi Division Launches Medicinal Mushroom Product Line Direct to Consumer and on Amazon
5/26/20228:35IHNWFeaturedSciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome
5/26/202206:45BWReata Pharmaceuticals Announces FDA Filing Acceptance and..
5/24/202212:38TRMNGoldman Sachs Thinks Reata Pharmaceuticals’ Stock is Going..
5/12/202203:36TRMNReata Pharmaceuticals (RETA) Receives a Hold from SVB..
5/10/202206:40BWReata Pharmaceuticals, Inc. Announces First Quarter 2022..
5/08/202211:08TRMNSVB Securities Sticks to Its Hold Rating for Reata..
5/02/202216:31BWReata Pharmaceuticals, Inc. to Report First Quarter 2022..
4/29/202207:03EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/01/202221:58TRMNAnalysts Offer Insights on Healthcare Companies: Bolt..
3/31/202216:55BWReata Pharmaceuticals Completes Rolling Submission of New..
3/29/202222:36TRMNLeerink Partners Maintains a Hold Rating on Reata..
3/29/202222:26TRMNRobert W. Baird Remains a Hold on Reata Pharmaceuticals..
3/29/202208:45TRMNAnalysts Offer Insights on Healthcare Companies: Lemaitre..
3/28/202216:06SEEKReata defended at Citi after FDA comments on ALS drug
3/28/202212:57SEEKAMC, VIEW and COE among mid-day movers
3/24/202210:29SEEKReata draws Buy rating at Goldman on potential for..
3/10/202211:32EDGARSchedule 13g
(sc 13g/a)
3/03/202205:22TRMNRobert W. Baird Reaffirms Their Hold Rating on Reata..
2/28/202208:31SEEKReata Pharmaceuticals down 5% on FDA rejection, revenue miss
2/28/202206:53SEEKReata Pharmaceuticals Non-GAAP EPS of -$1.59 beats by $0.34,..
2/28/202206:47EDGARCurrent Report Filing (8-k)
2/28/202206:45BWReata Pharmaceuticals, Inc. Announces Fourth Quarter and..
2/25/202220:45SEEKReata slips as FDA rejects kidney disease therapy
2/25/202217:30BWReata Pharmaceuticals Receives Complete Response Letter From..
2/18/202209:30PRNUSRETA SHAREHOLDER ALERT: Jakubowitz Law Reminds Reata..
2/18/202206:45BWReata Pharmaceuticals, Inc. To Report Fourth Quarter and..
2/16/202209:30PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2/11/202206:00PRNUSRETA SHAREHOLDER ALERT: Jakubowitz Law Reminds Reata..
2/10/202211:33EDGARSchedule 13g
2/10/202209:17EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202206:00PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2/07/202216:19EDGARInitial Statement of Beneficial Ownership (3)
2/07/202216:11EDGARInitial Statement of Beneficial Ownership (3)
2/07/202216:06EDGARCurrent Report Filing (8-k)
2/04/202216:21EDGARStatement of Ownership (sc 13g)
2/04/202209:25EDGARSchedule 13g
2/04/202206:00PRNUSRETA SHAREHOLDER ALERT: Jakubowitz Law Reminds Reata..
1/31/202207:43DJNReata Begins Rolling FDA Submission of Omaveloxolone in..
1/31/202207:28SEEKReata initiates rolling submission of omaveloxolone..
1/31/202206:45BWReata Pharmaceuticals Initiates Rolling Submission of New..
1/28/202213:47PRNUSRETA SHAREHOLDER ALERT: Jakubowitz Law Reminds Reata..
1/26/202217:31PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
1/13/202223:12PRNUSFILING DEADLINE--Kuznicki Law PLLC Announces Class Action on..
1/05/202220:57TRMNStrong Insider Buying Could Indicate a Bottom in These 3..
1/05/202217:23EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202216:11EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202216:10EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202216:10EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202216:09EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202216:08EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202216:05EDGARStatement of Changes in Beneficial Ownership (4)


Your Recent History
NASDAQ
RETA
Reata Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.